Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
Public ClinicalTrials.gov record NCT00055562. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Controlled, Double-Blind, Parallel-Group Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma Whose Disease Has Progressed on Treatment With DTIC, IL-2 or IFN Based Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Subjects are randomized to one of two treatment arms. All subjects are screened for eligibility within 28 days prior to randomization. The study consists of a treatment phase and a follow-up phase. Subjects will be treated in repeating 4 week cycles.
Study identification
- NCT ID
- NCT00055562
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 274 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2003 (Type not available)
- Primary completion
- Not listed
- Completion
- Dec 2004 (Type not available)
- Last update posted
- Jun 24, 2005
2003 – 2004
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| University of Southern California Norris Cancer Center | Los Angeles | California | 90089 | — |
| UCLA | Los Angeles | California | 90095-6956 | — |
| St. Francis Memorial Hospital | San Francisco | California | 94109 | — |
| Outpatient Clinic | Santa Monica | California | 90404 | — |
| University of Colorado | Aurora | Colorado | 80010 | — |
| The Harold Lever Regional Cancer Center | Waterbury | Connecticut | 06708 | — |
| Lakeland Regional Cancer Center | Lakeland | Florida | 33804-1057 | — |
| Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| Lutheran General | Park Ridge | Illinois | 60068-1270 | — |
| Carle Clinic | Urbana | Illinois | 61801 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02214-2698 | — |
| Beth Israel Deaconess Medical Ctr | Boston | Massachusetts | 02215-5400 | — |
| Spectrum Health | Grand Rapids | Michigan | 49503 | — |
| Ellis Fischel Cancer Center | Columbia | Missouri | 65203 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Melanoma Center of St Louis | St Louis | Missouri | 63131 | — |
| Biomedical Research Alliance of New York | New York | New York | 10016 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | — |
| The Linder Clinical Trial Center | Cincinnati | Ohio | 45219 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Penn State Hershey Medical Center | Hershey | Pennsylvania | 17033-0850 | — |
| UPMC Cancer Pavillion | Pittsburgh | Pennsylvania | 15232 | — |
| Sarah Cannon Cancer Center | Nashville | Tennessee | 37203-1632 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030-4009 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00055562, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00055562 live on ClinicalTrials.gov.